OTCBB ALERTS

[Mandroid]

MLHP - NEWS -Millenia Hope Inc.
(OTC Bulletin Board: MLHP), a Bio-Pharma Corporation, is pleased to announce
that through its Canadian subsidiary, Millenia Hope Bio-Pharma, it is in the
process of acquiring assets and expertise of a cutting-edge Canadian
Bio-Pharma firm. This acquisition will both broaden and deepen Millenia
Hope's ability to improve the efficacy of its flagship product MMH
Malarex(TM)/MMH 18(TM) and bring new, innovative products to market.
Simultaneously, this acquisition will give the company access to a unique
technology platform in phytomics, in great demand internationally by multi-
national cosmetic and pharmaceutical corporations. The outsourcing of
laboratory research is a multi-billion dollar business annually and Millenia
will be firmly entrenched in this lucrative market with its new acquisition.
About Millenia Hope:
Millenia Hope develops innovative treatments and quality products that
will increase the quality of life, provide tools in the fight against
diseases, and promote healthier lives. Our team is committed to research and
development to deliver on global medical needs and to bring hope through
healthcare solutions.
Safe Harbor Statement:
Certain statements made in this release may contain language describing
the plans, goals, strategies, intentions, forecasts and expectations of
Millenia Hope that may be referred to as "forward-looking statements."
Several important factors could cause actual results to differ materially from
those in such forward-looking statements, and Millenia Hope could encounter
unanticipated obstacles and delays in developing products, services and
markets.
For more information:

Please contact: Mr. Hugo Valente, CFO
Tel.: [phone] or 514-288-8822
http://www.milleniahope.com
[e-mail]
This release was issued through eReleases(TM). For more information,
visit http://www.ereleases.com.
SOURCE Millenia Hope Inc.


Contact Information:
Mr. Hugo Valente, CFO, Millenia Hope Inc., [phone] or [phone], [e-mail]